World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
76
Citations
21746
World Ranking
1908
National Ranking
931

Medicine

D-Index
76
Citations
21768
World Ranking
18765
National Ranking
9350

Gerd Ritter publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gerd Ritter sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 193 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gerd Ritter D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gerd Ritter sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gerd Ritter is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans biochemistry, genetics, molecular biology, and medicine, with a focus on molecular biology and subfields related to immunology, allergy, and oncology.

Their work emphasizes the study of specific biological processes such as TGF-β signaling in diseases, cell adhesion molecules, and cancer cell behavior including metastasis. These topics indicate a deep engagement with cellular signaling pathways and mechanisms involved in cancer progression and immune response modulation.

Ritter's recent publications include:

  • Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer, 2021, Communications Biology
  • 567 Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of stroma poor cancers, 2021, Regular and Young Investigator Award Abstracts

Their research contributions are documented in venues such as Communications Biology and Regular and Young Investigator Award Abstracts, illustrating participation in both peer-reviewed journals and conference abstracts.

Frequent collaborators in their research projects are:

  • Aditi Gupta
  • Sadna Budhu
  • Rachel Giese
  • Adam O. Michel
  • Aliya Holland

This network of coauthors suggests ongoing collaborative efforts across multiple studies, often involving investigations related to TGF-β signaling and cancer biology.

Best Publications

  • Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

    Eiichi Sato;Sara H. Olson;Jiyoung Ahn;Brian Bundy

  • Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses

    Sacha Gnjatic;Djordje Atanackovic;Elke Jäger;Mitsutoshi Matsuo

  • Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.

    P O Livingston;G Y Wong;S Adluri;Y Tao

  • NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.

    Ian F. Hermans;Jonathan D. Silk;Uzi Gileadi;Mariolina Salio

  • Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

    Elke Jäger;Sacha Gnjatic;Yasuhiro Nagata;Elisabeth Stockert

  • Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

    E Jäger;Y Nagata;S Gnjatic;H Wada

  • NY-ESO-1: review of an immunogenic tumor antigen.

    Sacha Gnjatic;Hiroyoshi Nishikawa;Achim A Jungbluth;Ali O Güre

  • The crystal structure of human CD1d with and without alpha-galactosylceramide.

    Michael Koch;Victoria S Stronge;Dawn Shepherd;Stephan D Gadola

  • Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non–Small Cell Lung Cancer

    Ali O. Gure;Ramon Chua;Barbara Williamson;Mithat Gonen

  • Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma

    Elke Jäger;Dirk Jäger;Julia Karbach;Yao-Tseng Chen;Yao-Tseng Chen

  • Colon cancer associated transcript-1: A novel RNA expressed in malignant and pre-malignant human tissues

    Aviram Nissan;Alexander Stojadinovic;Stella Mitrani-Rosenbaum;David Halle

  • Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

    Paul Sabbatini;Takemasa Tsuji;Luis Ferran;Erika Ritter

  • Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer

    Kunle Odunsi;Feng Qian;Junko Matsuzaki;Paulette Mhawech-Fauceglia

  • NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

    Kunle Odunsi;Achim A. Jungbluth;Elisabeth Stockert;Feng Qian

  • Structure of Human Cd1B with Bound Ligands at 2.3 A, a Maze for Alkyl Chains

    Stephan D. Gadola;Stephan D. Gadola;Nathan R. Zaccai;Karl Harlos;Dawn Shepherd

  • Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events.

    Elke Jäger;Elisabeth Stockert;Zacharias Zidianakis;Yao-Tseng Chen;Yao-Tseng Chen

  • Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

    Elke Jäger;Julia Karbach;Sacha Gnjatic;Antje Neumann

  • Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets.

    Matthew J. Scanlan;Sydney Welt;Claudia M. Gordon;Yao-Tseng Chen

  • Dramatically Different Phenotypes in Mouse Models of Human Tay-Sachs and Sandhoff Diseases

    Daniel Phaneuf;Nobuaki Wakamatsu;Jing-Qi Huang;Anita Borowski

  • RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses.

    Michael Schmitt;Anita Schmitt;Markus T. Rojewski;Jinfei Chen

Frequent Co-Authors

Lloyd J. Old
Lloyd J. Old Ludwig Cancer Research
Sacha Gnjatic
Sacha Gnjatic Icahn School of Medicine at Mount Sinai
Achim A. Jungbluth
Achim A. Jungbluth Memorial Sloan Kettering Cancer Center
Yao-Tseng Chen
Yao-Tseng Chen Cornell University
Alexander Knuth
Alexander Knuth University of Zurich
Elke Jäger
Elke Jäger Goethe University Frankfurt
Hiroyoshi Nishikawa
Hiroyoshi Nishikawa Nagoya University
Kunle Odunsi
Kunle Odunsi Roswell Park Cancer Institute
Hiroshi Shiku
Hiroshi Shiku Mie University
Antony W. Burgess
Antony W. Burgess Walter and Eliza Hall Institute of Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in immunology, exploring related healthcare degrees can open diverse career opportunities. Programs such as Licensed Practical Nurse (LPN) degrees offer a foundational entry into the medical field. If you're seeking accessible options, look into the easy admission LPN programs which provide a streamlined path into nursing careers.

Advancing in nursing can lead to specialties like the Nurse Practitioner (NP) role. Some of the easiest NP programs to get into might be appealing if you want to pursue advanced practice nursing with minimal barriers to entry.

For those interested in mental health, Psychiatric Mental Health Nurse Practitioner (PMHNP) programs offer specialized training. Choosing from the best online PMHNP programs ensures strong clinical placements, facilitating hands-on learning and smoother career transitions.

Cost is also a major factor. Thankfully, there are cheapest psych NP programs that combine quality education with affordability, making advanced nursing education more accessible to a wider audience. These pathways complement an immunology background, paving the way for impactful roles in healthcare and research.

Best Scientists Citing Gerd Ritter

Trending Scientists